APEPTICO Forschung und Entwicklung

company

About

APEPTICO is a biotech company developing new peptide-based medicinal drugs for the treatment of severe and chronic diseases.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$3.95M
Industries
Biopharma,Biotechnology,Therapeutics
Founded date
Jan 1, 2009
Number Of Employee
1 - 10
Operating Status
Active

APEPTICO is an innovative biotech company that develops new peptide-based medicinal drugs for the therapeutic and prophylactic treatment of severe and chronic diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.95M
APEPTICO Forschung und Entwicklung has raised a total of $3.95M in funding over 2 rounds. Their latest funding was raised on Aug 5, 2010 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2010 Series A $3.95M 1 BioScience Ventures Group Detail

Investors

Number of Lead Investors
Number of Investors
1
1
APEPTICO Forschung und Entwicklung is funded by 1 investors. BioScience Ventures Group are the most recent investors.
Investor Name Lead Investor Funding Round
BioScience Ventures Group Yes Series A